Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus
NCT01107132 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2010-04-20
Summary
In Type 2 Diabetes mellitus patients we will:
1. quantify vasculopathy and blood-retinal barrier (BRB) leakage
2. measure blood-brain barrier (BBB) permeability and neuroanatomical changes
3. correlate BRB pathology with BBB breakdown, inflammatory markers and neuropsychiatric sequela
Conditions
Sponsors & Collaborators
-
Soroka University Medical Center
lead OTHER
Principal Investigators
-
Hadar Shalev, M.D · Soroka University Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
Countries
- Israel
Study Locations
More Related Trials
-
Myelin, Glia and Depression in Type 2 Diabetes
NCT01327404 ·Status: COMPLETED
-
Conjunctival and Retinal Vascularization and Small Vessel Disease
NCT04447599 ·Status: UNKNOWN ·Phase: NA
-
ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease
NCT03739905 ·Status: COMPLETED ·Phase: NA
-
Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD
NCT03389698 ·Status: COMPLETED
-
Eye to Brain Connection
NCT05215782 ·Status: COMPLETED
-
Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT
NCT00958815 ·Status: COMPLETED
-
Functional MRI Biomarkers of Cognitive Decrements in Diabetes
NCT01705210 ·Status: COMPLETED
-
The Value of Combined Detection of Different Blood Biomarkers in the Diagnosis and Treatments of Traumatic Brain Injury
NCT06854835 ·Status: NOT_YET_RECRUITING
-
A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy
NCT01801306 ·Status: COMPLETED ·Phase: NA
-
Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease
NCT04526262 ·Status: UNKNOWN ·Phase: NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
NCT06103201 ·Status: RECRUITING ·Phase: PHASE1
-
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161 ·Status: COMPLETED
-
Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military
NCT04058132 ·Status: TERMINATED ·Phase: PHASE2
-
Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury
NCT03139682 ·Status: COMPLETED
-
Blood-brain Barrier Permeability Study in Adults With Meningitis
NCT02902588 ·Status: TERMINATED ·Phase: NA
-
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
NCT06158789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Vessel Wall and Perfusion Imaging in Intracranial Atherosclerosis
NCT02719652 ·Status: UNKNOWN
-
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
NCT03366129 ·Status: COMPLETED
-
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
NCT07314190 ·Status: ENROLLING_BY_INVITATION
-
Intraoperative Fluorescence With Augmented Reality
NCT03888014 ·Status: COMPLETED
-
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
NCT06289582 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Dysregulated CNS Inflammation After Acute Brain Injury
NCT03287557 ·Status: COMPLETED
-
Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)
NCT03313817 ·Status: COMPLETED
-
1-hour Post-load Hyperglycemia and Mild Cognitive Impairment
NCT03363516 ·Status: UNKNOWN
-
MRI Study of the Structural and Functional Rehabilitation in the Cerebral Infarction Patients With Diabetes
NCT02540733 ·Status: UNKNOWN